Ravi Medarametla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ravi Medarametla has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Ashok Runkana
Baptist Medical Center South Montgomery Alabama USA
2 shared publications - Adil Sarvar Mohammed
Department of Internal Medicine, Central Michigan University, Saginaw, Mi 48602, USA
1 shared publication - Atul Prakash
St. Mary's General Hospital Passaic New Jersey USA
1 shared publication - Gaurav Patel
St. Mary's General Hospital Passaic New Jersey USA
1 shared publication - Hema Narayanasamy
Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, USA
1 shared publication James B. Hermiller
1 shared publication
Latest Publications
- Open Access
- 30 October 2026
- Published by Springer Nature in Cardio-Oncology
Prevalence of atrial fibrillation in cancer patients treated with radiation therapy: a systematic review and meta-analysis
- 30 October 2026
- Published by Springer Nature in Cardio-Oncology
Open AccessPrevalence of atrial fibrillation in cancer patients treated with radiation therapy: a systematic review and meta-analysis
- 26 August 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
Bachmann's Bundle Versus Right Atrial Appendage Pacing: A Systematic Review and Meta‐Analysis
Background: Right atrial appendage (RAA) pacing remains the default atrial lead position despite evidence that non‐physiological atrial activation promotes interatrial dyssynchrony. Bachmann's bundle pacing (BBp) targets the interatrial conduction pathway. We evaluated whether BBp improves electrophysiologic markers of atrial synchrony and whether this is accompanied by a reduction in atrial fibrillation (AF) incidence compared with RAA pacing. Methods: Systematic review and meta‐analysis of studies comparing BBp with RAA pacing. PubMed, Embase, Scopus, Cochrane Library, ClinicalTrials.gov, and reference lists were searched (December 2025). Primary outcome: P‐wave duration change. Secondary: AF incidence. Safety: lead dislodgement. Random‐effects (REML) models. Results: Eight studies comprising 731 patients were analyzed. BBp was associated with a consistent reduction in P‐wave duration (primary analysis, 5 independent‐group studies: MD −34.61 ms; 95% CI −39.84 to −29.38; p < 0.001; I 2 = 0%; 6‐study sensitivity including Vedage et al.: MD −35.24 ms; I 2 = 0%), indicating a shortening of global atrial activation time. BBp was also associated with a lower AF incidence across three RCTs (RR 0.59; 95% CI 0.37–0.94; p = 0.026); however, this estimate was imprecise and sensitive to removal of the dominant contributing trial. Atrial lead dislodgement was rare and events were insufficient for formal pooled analysis; no excess dislodgement signal was observed, but comparative safety remains uncertain given event sparsity. Conclusions: BBp consistently reduced P‐wave duration across diverse paced populations and generated a fragile signal toward lower AF incidence. Comparative lead safety is uncertain due to sparse events. These findings support investigation in prospective trials but do not justify immediate practice change. PROSPERO Registration: CRD420261282981.
- 26 August 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
Bachmann's Bundle Versus Right Atrial Appendage Pacing: A Systematic Review and Meta‐Analysis
Background: Right atrial appendage (RAA) pacing remains the default atrial lead position despite evidence that non‐physiological atrial activation promotes interatrial dyssynchrony. Bachmann's bundle pacing (BBp) targets the interatrial conduction pathway. We evaluated whether BBp improves electrophysiologic markers of atrial synchrony and whether this is accompanied by a reduction in atrial fibrillation (AF) incidence compared with RAA pacing. Methods: Systematic review and meta‐analysis of studies comparing BBp with RAA pacing. PubMed, Embase, Scopus, Cochrane Library, ClinicalTrials.gov, and reference lists were searched (December 2025). Primary outcome: P‐wave duration change. Secondary: AF incidence. Safety: lead dislodgement. Random‐effects (REML) models. Results: Eight studies comprising 731 patients were analyzed. BBp was associated with a consistent reduction in P‐wave duration (primary analysis, 5 independent‐group studies: MD −34.61 ms; 95% CI −39.84 to −29.38; p < 0.001; I 2 = 0%; 6‐study sensitivity including Vedage et al.: MD −35.24 ms; I 2 = 0%), indicating a shortening of global atrial activation time. BBp was also associated with a lower AF incidence across three RCTs (RR 0.59; 95% CI 0.37–0.94; p = 0.026); however, this estimate was imprecise and sensitive to removal of the dominant contributing trial. Atrial lead dislodgement was rare and events were insufficient for formal pooled analysis; no excess dislodgement signal was observed, but comparative safety remains uncertain given event sparsity. Conclusions: BBp consistently reduced P‐wave duration across diverse paced populations and generated a fragile signal toward lower AF incidence. Comparative lead safety is uncertain due to sparse events. These findings support investigation in prospective trials but do not justify immediate practice change. PROSPERO Registration: CRD420261282981.
- Open Access
- 4 August 2026
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 5 (9)
Mechanical Thrombectomy Versus Systemic Thrombolysis in Hemodynamically Unstable High-Risk Pulmonary Embolism Requiring Vasopressors: A Propensity-Matched Outcomes Analysis From TriNetX Network
- 4 August 2026
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 5 (9)
Open AccessMechanical Thrombectomy Versus Systemic Thrombolysis in Hemodynamically Unstable High-Risk Pulmonary Embolism Requiring Vasopressors: A Propensity-Matched Outcomes Analysis From TriNetX Network